Loading organizations...
Key people at Elastic Care Inc.
Elastic Care Inc is a Markham, Ontario healthcare technology company that develops LifePath, an AI-based medical platform designed for precise, real-time remote patient monitoring. This low-cost system facilitates continuous cardiac tracking outside of traditional clinical environments, specifically engineered for easy setup and deployment in residential settings and remote locations. By focusing on accessible healthcare delivery, the enterprise provides observation capabilities for immobile or frail individuals and patients with special needs without requiring hospital admission. The company's development and strategic operations are guided by a team of medical and technology professionals, including cardiologist Dr Ilan Lashevsky, medical strategy head Dr Bishnu Panigrahi, and Healthtech Consultants chief executive officer Susanne Flett. Additional technical leadership includes CTO Akshay and system architect Todd Daynes, although the organization's founding year and business model remain undisclosed in public records.
Key people at Elastic Care Inc.
Elastic Care Inc. is a Canadian healthcare technology company developing LifePath, an AI-based medical-grade software and hardware platform for remote patient monitoring. Based in Markham, Ontario, and part of the Pathway Group, it targets vulnerable patients in home or remote settings, monitoring vital signs for conditions like cardiovascular diseases, diabetes, and COPD in real time.[1][3][6] LifePath serves healthcare providers and patients by providing alerts, trends, and customizable schedules via physician and patient apps, reducing costs and enabling early interventions outside hospitals.[1][3][7] The platform integrates FDA-cleared third-party devices for non-intrusive, precise monitoring, emphasizing low-cost setup and deployment.[1][4][7]
Elastic Care Inc., headquartered at 95 Apple Creek Blvd in Markham, Ontario, operates as a small firm with under 25 employees and revenue below $5 million.[3] Specific founding year, founders, or early traction details are not detailed in available sources, though its LifePath platform received FDA 510(k) clearance (K211822) on February 3, 2022, marking a pivotal regulatory milestone for its remote monitoring capabilities.[7] The company emerged in the telemedicine space, focusing on AI-driven solutions for chronic care, with Prithul Bom listed as a key contact in FDA submissions.[7] As part of Pathway Group, it builds on Canadian healthcare tech innovation, prioritizing hospital-level care at home.[1]
Elastic Care rides the remote patient monitoring (RPM) trend accelerated by COVID-19, enabling hospital-level care at home amid rising chronic disease prevalence and telemedicine adoption.[1][6] Its 2022 FDA clearance aligns with market forces like aging populations, healthcare cost pressures, and AI integration in medtech, positioning it favorably in Canada's healthtech ecosystem.[3][7] By reducing hospital readmissions through real-time data for providers, it influences broader shifts toward decentralized care, complementing platforms like Comarch e-Care while emphasizing AI for cardiac/telemedicine niches.[7] This supports global pushes for accessible monitoring, though competition from larger players highlights its agile, low-cost niche.[3]
Elastic Care's FDA-cleared LifePath positions it for expansion in RPM, potentially scaling via partnerships for chronic care in underserved areas.[7] Upcoming trends like advanced AI analytics, wearable integrations, and regulatory harmonization (e.g., beyond U.S. to Canada/EU) could drive growth, with one noted clinical trial signaling R&D momentum.[2] Its influence may evolve through Pathway Group synergies, targeting diabetes/COPD beyond cardiac, though limited public news suggests a need for visibility to attract funding/partners.[3] As RPM demand surges, Elastic Care exemplifies how precise, affordable tech humanizes care for vulnerable patients, tying back to its core mission of precision and innovation at home.[1]
